Industries — page 16
Venu Plans Financing Shift to Keep Venue Real Estate
Venu closed $45 million in interim financing after quarter-end while pursuing longer-term funding to complete two amphitheaters.
TSS Systems Integration Growth Slows After First-Quarter Pace
Second-quarter revenue was $35.1 million as systems integration rose 46% to $13.9 million and procurement fell 45%.
Tapestry Hits Investor-Day Targets Two Years Early
Fourth-quarter sales were $1.88 billion, up 9%, as the company met 2028 revenue, margin and EPS goals and set a $8.4 billion to $8.5 billion 2027 outlook.
Soluna Completes Dorothy 1 Vertical Integration
Revenue reached $15.1 million, up 60% sequentially, as the company booked Briscoe’s first quarter and expanded its pipeline to about 6.3 gigawatts.
QXO Restores Profit After Kodiak Close
Adjusted EBITDA was $272 million on $3.25 billion of sales after a $1.2 million first quarter.
Knicks Title Lifts MSGS Fourth-Quarter Sales 37%
Revenue reached $278.7 million as playoff-related sales rose $66.9 million and the company swung to a $32.2 million operating profit from a $22.6 million loss a year earlier.
Merlin Completes C-130J Design Review and Autonomous Landing
Second-quarter revenue was $2.2 million as the company posted a $58.4 million GAAP net loss.
MeiraGTx Reclaims Eye Therapy Ahead of Regulatory Push
The genetic medicines company completed its $25 million acquisition of bota-vec and secured financing to support development and potential commercialization.
MacroGenics Completes Bora Sale, Cuts Staff to About 140
Pro forma cash of $327 million as of June 30, 2026, including Bora, Sanofi and Gilead proceeds, underpins runway guidance through 2028.
Lifeway Foods’ Margin Gains Reversed
The kefir maker posted just $0.1 million in second-quarter net income as higher input costs eroded profitability.
Chicago Atlantic BDC Funding Collapses After Record Quarter
Second-quarter investment income was $14.0 million, or $0.61 a share, as the cannabis-focused BDC funded just $2.7 million.
KULR Reverses First-Quarter Revenue Gain and Exits Bitcoin Mining
Second-quarter revenue fell 43% to $2,080,177 and gross margin swung to (31)% after a 98% year-over-year first-quarter increase.
Invivyd Completes Upsized DECLARATION Enrollment
PEMGARDA net product revenue was $14.3 million, up 21% from a year earlier, as the company completed enrollment in its upsized pivotal trial and said cash of $160.1 million should last through the VYD2311 readout.
Indaptus Ends Decoy20 Enrollment, Has No Active Clinical Programs
A $12.0 million June private placement left Indaptus with $11.6 million in cash, cash equivalents and short-term investments as it wound down Decoy20.
Dillard's Comparable Sales Slow After First-Quarter Lift
Retail gross margin reached 40.9% of sales after $37.2 million of IEEPA tariff refunds lifted the rate by 260 basis points.
CapsoVision Capsule Sales Rebound After a Flat First Quarter
Second-quarter revenue reached $3.6 million as capsule volume rose 13% and the company launched AI Highlights in Europe.
Boston Omaha to Sell Insurance Unit for $84.3 Million
The Omaha holding company agreed to sell General Indemnity Group to CopperPoint for about $84.3 million as second-quarter revenue reached $22.20 million.
Applied Materials Raises Calendar 2026 Systems Outlook
The equipment maker guided fourth-quarter revenue to $10.25 billion plus or minus $500 million after a record $9.12 billion quarter.
Applied Industrial Raises Long-Range Sales and EBITDA Targets
Fiscal 2027 EPS is guided to $11.65 to $12.15 after a 9.7% organic sales gain in the June quarter.
AIRO Restores Operating Profit After First-Quarter Loss
Second-quarter revenue reached $43.2 million, up 76% from a year earlier, and gross margin recovered to 64%.
Trimble Raises 2026 Outlook After Record Recurring Revenue
Annualized recurring revenue reached a record $2.51 billion as the company lifted full-year revenue guidance to $3.90 billion–$3.95 billion.
Bio-Techne Organic Sales Rebound After a Third-Quarter Drop
Fourth-quarter organic revenue rose 3% to $321.2 million as the company agreed to be bought by Merck KGaA for $73 a share.
Sutro Reports Early STRO-004 Responses in Phase 1
The company posted $9.8 million of second-quarter revenue and $164.3 million of cash as it optimized STRO-004 between 4 and 5 mg/kg.
Omega Flex Sales Decline Widens After Housing-Starts Drag
Second-quarter net sales were $24.06 million, 5.8% below a year earlier, and net income fell 35.6% to $2.68 million.
M-tron's Adjusted EBITDA Growth Accelerates
Adjusted EBITDA rose 40.6% to $3.4 million in the three months ended June 30, 2026, as backlog reached $84.0 million.
Lexeo Starts LX2006 Pivotal Trial, Wins RMAT for LX2020
Cash, cash equivalents and investments were $234.2 million as of June 30, 2026, which the company said it expects to fund operations into 2028.
Liquidia Extends Profitability Streak on YUTREPIA Sales
Second-quarter net product sales reached $170.4 million, and cash rose to $284.2 million as the company posted a fourth straight quarter of higher profit.
Century Therapeutics Locks In CNTY-813 IND Path After FDA Meeting
Cash, cash equivalents, and investments were $197.2 million as of June 30, 2026, with runway still estimated into the first quarter of 2029.
Infleqtion Raises 2026 Outlook After Record Quantum Quarter
Second-quarter revenue reached a record $12.6 million, up 116% from a year earlier, and the company lifted its full-year target to about $43 million.
Humacyte ATEV Beats Fistula in Dialysis Trial
The company plans a supplemental BLA in the second half of 2026 after women on the vessel gained 91 more catheter-free days than those on AV fistula.
Brinker Completes Five Years of Chili’s Same-Store Growth
Fourth-quarter company sales reached $1.52 billion as Chili’s comps rose 5.6% and the board authorized $750 million of additional buybacks.
Cypherpunk Aligns With FDA on Sirexatamab Phase 3
The privacy-technology company posted $39.4 million of second-quarter net income as its Zcash treasury reached 323,394.38 ZEC.
Cisco's Revenue Growth Accelerates to 18% in Fourth Quarter
Fourth-quarter sales reached $17.3 billion, and the company guided first-quarter fiscal 2027 revenue to $18.0 billion to $18.2 billion.
Coherent's Fourth-Quarter Sales Growth Accelerates
Fourth-quarter revenue reached $2.05 billion, up 33.8% from a year earlier, and the company guided first-quarter fiscal 2027 sales to $2.2 billion to $2.4 billion.
Capstone Energy+ Gross Margin Reaches 35% on Mix Shift
Gross profit rose 16% to $8.8 million in the fiscal first quarter ended June 30, 2026, as the company swung to $1.0 million of operating income.
Ambiq Posts Record Sales, Signals Slower Growth
Second-quarter net sales reached $33.901 million, topping Ambiq’s previous guidance ceiling by $1.901 million.
Venture Global Profit Nearly Triples as LNG Shipments and Margins Surge
The liquefied natural gas exporter posted $1.3 billion in second-quarter net income, a 266% jump from a year earlier, and raised its full-year EBITDA guidance to as much as $9.1 billion.
Tyson Foods Refinances Debt, Presses Ahead on Beef Overhaul
Tyson Foods raised $1 billion in new notes to retire older debt as the meat producer closes a Nebraska beef plant and works through a leadership handoff.
Neuronetics Turns Adjusted Ebitda Positive in Second Quarter
Greenbrook clinics posted $26.9 million of revenue as the interventional mental-health company swung to a $0.3 million adjusted Ebitda profit.
Smart Sand Raises Annual Volume Growth Forecast
Smart Sand reported record quarterly revenue of $115.1 million and raised its forecast for annual sand sales-volume growth.
Sanara MedTech Agrees to Be Acquired by MIMEDX
Second-quarter net revenue was $28.1 million as year-over-year growth slowed to 9% from 19% in the first quarter.
RideNow's Same-Store Growth Cools After a First-Quarter Spike
Same-store powersports revenue rose 3.0% to $291.5 million in the three months ended June 30, 2026, after a 13.1% year-over-year increase in the first quarter.
NIQ Global Intelligence Raises 2026 Outlook as Cash Flow Inflects
Annualized Intelligence Subscription revenue surpassed $3 billion for the first time in the second quarter.
Microvast Sequential Sales Recover After First-Quarter Drop
Second-quarter revenue was $87.3 million, with $2.7 million of IEEPA tariff refunds booked as a cut to sales.
Middleby Raises Outlook as Organic Growth Accelerates
Adjusted earnings increased to $2.35 a share despite transaction costs and margin pressure.
Lumentum Revenue Doubles Year-Over-Year as AI Demand Accelerates
The optical-components maker posted $1.006 billion in quarterly revenue, surpassing the high end of its own guidance, and projected another 24% sequential jump for the current quarter.
Immunic Names Lundgren Chief Executive Officer
The late-stage biotech ended June with $155.1 million in cash after a February private placement and said ENSURE top-line data are expected by the end of 2026.
Inhibikase Starts 43 Sites After 26-Country Trial Approvals
Cash, cash equivalents and marketable securities were $159.0 million at June 30, 2026, after a $50 million RA Capital sale in July.
Codexis Reiterates 2026 Outlook After July Equity Raise
The enzymatic-therapeutics maker booked $14.9 million of second-quarter revenue and said proforma cash of about $80 million will fund operations through the end of 2028.
Cardinal Health raises share buyback as annual earnings exceed guidance
The healthcare services company reported fiscal year non-GAAP diluted earnings per share of $11.26, surpassing its previous guidance range of $10.70 to $10.80.